Breamy: An augmented reality mHealth prototype for surgical decision-making in breast cancer 38 MICCAI Workshop Paper The idea of Breamy emerged from a team of graduate students (Miranda Addie, Chelsea De Bellis, Ujjwala Naithani, Niki Najafi, and Tanushree Paul) taking part in the NSERC CREATE Surgical Innovation program (delivered jointly by McGill, Concordia and École de technologie supérieure) with clinical guidance from Sarkis Meterissian, MD, Director of the Breast Center at McGill University Health Centre (MUHC). Niki Najafi is a graduate student in Computer Science at Concordia University supervised by Marta KerstenOertel. She recently presented an augmented reality mobile app, Breamy, for more informed surgical decision-making in breast cancer at the AE-CAI workshop (MICCAI 2023). Did you know that 1 in 8 women will be diagnosed with breast cancer? Most diagnosed women will require surgery as part of their treatment. If women, with their surgeons, decide to proceed with a mastectomy, i.e., surgery to remove the breast, they must decide whether they desire breast reconstruction. However, the time from diagnosis to surgery is short – between 4-8 weeks. Coupled with the stress of a cancer diagnosis, these patients often feel overwhelmed by the life-altering decisions they have to quickly make. This type of time-sensitive decision-making process can lead to anxiety, decisional regret, and revision surgeries. Decision aids (DAs) help patients by providing detailed medical information, clarifying values, and engaging them in active decision-making. The use of DAs has been shown to aid collaborative and informed decision-making. Our goal is to develop smartphone technology to empower women to make more informed and personalized decisions. Our prototype, Breamy, uses AR to display various reconstructive options on a patient's body for more tailored decisions.
RkJQdWJsaXNoZXIy NTc3NzU=